Results 241 to 250 of about 59,693 (345)

Retrospective Evaluation of Transcatheter Edge‐To‐Edge Mitral Valve Repair in Dogs With Myxomatous Mitral Valve Disease

Journal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) is an emerging minimally invasive mitral valve repair treatment for dogs with myxomatous mitral valve disease (MMVD), but reports on its outcomes are limited. Objective Describe the clinical characteristics and complications in dogs with MMVD undergoing TEER.
Jeong‐Min Lee, Kyoung‐a Youp, Sun‐Tae Lee, Ah‐Ra Lee, Young‐Wook Cho, Youn‐Seo Jung, Jiwoong Her, Seung‐Keun Lee   +7 more
wiley   +1 more source

Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy. [PDF]

Front Endocrinol (Lausanne)
Nolan BJ, Accatino MI, Angus LM, Cheung AS.   +3 more
europepmc   +1 more source

Long‐Term Outcomes of Mitral Valve Repair With Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs

Journal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Myxomatous mitral valve disease (MMVD) in dogs commonly progresses to congestive heart failure, which carries a poor prognosis. Mitral valve repair (MVR) is a recognized treatment for advanced‐stage MMVD. Hypothesis/Objectives Identify the risk factors and prognosis in dogs undergoing MVR.
Kentaro Kurogochi, Shimon Furusato, Emi Takahashi, Miho Tabata, Masashi Mizuno, Yasuyuki Nii, Masami Uechi   +6 more
wiley   +1 more source

Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs

Journal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Methods to quantify the activity of the tissue renin–angiotensin system (RAS) are needed. Objective To estimate myocardial and renal RAS enzyme activity in postmortem tissues. Animals Convenience sample of 15 purpose‐bred laboratory dogs with experimental heartworm infection (Group 1) euthanized as part of an unrelated study and 22 ...
Emma C. Weitzhandler, Marisa K. Ames, Machelle D. Wilson, Oliver Domenig   +3 more
wiley   +1 more source

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic rats [PDF]

, 2001
Goran Miric, Catherine Dallemagne, Zoltán Endre, Solomon B. Margolin, Stephen M. Taylor, Lindsay Brown   +5 more
openalex   +1 more source

Agranulocytosis caused by spironolactone. [PDF]

BMJ, 1984
T. T. Oei, B H Stricker
openaire   +3 more sources

Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study

Pigment Cell &Melanoma Research, Volume 38, Issue 4, July 2025.
ABSTRACT The unique pharmacokinetics of BRAF and MEK inhibitors make patients vulnerable to drug–drug interactions (DDIs), which may compromise treatment efficacy in metastatic melanoma. This study evaluates the impact of DDIs on clinical outcomes in patients with metastatic melanoma treated with BRAF/MEK inhibitors.
Silvia Mezi, Andrea Botticelli, Giulia Pomati, Simone Scagnoli, Giulia Fiscon, Federica de Galitiis, Francesca Romana di Pietro, Sofia Verkhovskaia, Sasan Amirhassankhani, Giovanna Gentile, Maurizio Simmaco, Bjoern Gohlke, Robert Preissner, Daniele Santini, Paolo Marchetti   +14 more
wiley   +1 more source

Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Yu W, Luo F, Rao J, Lei G, Wu Q, Shen W, Yang P, Li P.   +7 more
europepmc   +1 more source

Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism

, 1996
Mithat Erenus, Deniz Yücelten, Oya Gürbüz, Fatih Durmuşoğlu, S. Pekin   +4 more
openalex   +1 more source

Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan. [PDF]

Int J Med Sci
Chien LN, Hsiao PJ, Chiu CC, Chen WT, Cheng CJ, Tsou LL, Kao YH, Chou CL, Fang TC.   +8 more
europepmc   +1 more source